INFAI

INFAI is a specialized biotechnology company focused on the development and commercialization of non-invasive diagnostic tests using stable isotope technology. The company's flagship product, the Helicobacter Test INFAI, is a gold-standard 13C-urea breath test used globally for the detection of Helicobacter pylori infections. Beyond gastroenterology, INFAI utilizes advanced NMR spectroscopy and mass spectrometry to develop diagnostic tools for metabolic diseases and oncology. The company operates facilities in Germany and the UK, providing both diagnostic kits and laboratory services to healthcare providers. Its technology platform is characterized by high sensitivity and specificity, offering a safe alternative to invasive diagnostic procedures.